Valuation: Proteome Sciences plc

Market Cap 4.73M 6.29M 5.67M 5.24M 8.96M 590M 9.18M 62.77M 25.02M 316M 23.61M 23.1M 1.01B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.72M 26.2M 23.62M 21.82M 37.32M 2.46B 38.24M 261M 104M 1.32B 98.34M 96.25M 4.19B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day-4.07%
1 week-11.00%
Current month-11.00%
1 month-4.78%
3 months-28.06%
6 months-26.00%
Current year-48.20%
1 week 1.1
Extreme 1.1
1.69
1 month 1.1
Extreme 1.1
1.7
Current year 1.1
Extreme 1.1
4.4
1 year 1.1
Extreme 1.1
4.4
3 years 1.1
Extreme 1.1
6.3
5 years 1.1
Extreme 1.1
8.79
10 years 1.1
Extreme 1.1
10
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 64 16/10/2014
Date Insider Type Main position Quantity % Market Cap. Importance
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
6/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-4.07%-11.00%-21.52%-77.67% 6.29M
-0.96%-4.77%-16.02%+12.93% 189B
+0.27%-3.06%+6.07%+41.00% 124B
-0.83%-5.78%-14.05%+12.02% 121B
-1.45%-6.28%-43.90%+1.78% 93.09B
+0.28%+3.28%-3.46%+76.41% 66.77B
+0.39%+0.89%+12.14%-8.65% 58.43B
+0.16%+4.75%-1.54%+62.48% 55.35B
+0.96%-1.33%-3.37%+57.35% 49.49B
+1.34%-3.98%-5.90%-8.14% 34.53B
Average -0.42%-2.78%-9.16%+16.95% 79B
Weighted average by Cap. -0.32%-3.10%-10.15%+24.96%

Financials

2024 2025
Net sales 4.89M 6.49M 5.85M 5.41M 9.25M 609M 9.47M 64.79M 25.82M 326M 24.36M 23.85M 1.04B 3.76M 4.99M 4.5M 4.15M 7.11M 468M 7.28M 49.79M 19.85M 251M 18.73M 18.33M 798M
Net income -3.41M -4.52M -4.08M -3.77M -6.44M -424M -6.6M -45.15M -18M -227M -16.98M -16.62M -723M -3.06M -4.07M -3.67M -3.39M -5.79M -381M -5.93M -40.58M -16.17M -204M -15.26M -14.94M -650M
Net Debt 13.39M 17.79M 16.04M 14.82M 25.34M 1.67B 25.97M 178M 70.77M 894M 66.78M 65.36M 2.84B 14.99M 19.91M 17.95M 16.58M 28.36M 1.87B 29.06M 199M 79.2M 1B 74.73M 73.14M 3.18B
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
13/11/26 GBX 1.295 -4.07% 194,690
11/11/26 GBX 1.350 -7.22% 139,611
10/11/26 GBX 1.455 +0.34% 5,659
09/11/26 GBX 1.450 +5.07% 108,266
06/11/26 GBX 1.380 -5.15% 137